Biocides Market is Forecasted to Reach 1,376.6 Kilotons by 2024: P&S Intelligence
/
Date30 Jul 2019
Email Print Friendly Share NEW YORK, July 30, 2019 (GLOBE NEWSWIRE) — Major players operating in the biocides market includes BASF SE, DowDuPont Inc., Lanxess... Read More →
Coherus BioSciences Reports Victory in Pegfilgrastim Patent Dispute
/
Date30 Jul 2019
Email Print Friendly Share REDWOOD CITY, Calif., July 29, 2019 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (“Coherus” or “the Company”, Nasdaq: CHRS), today announced that... Read More →
Mid-Con Energy Partners, LP Announces the Appointment of Chief Operating Officer, Schedules Second Quarter 2019 Earnings Release and Conference Call and Announces Quarterly Distribution on Preferred Units
/
Date30 Jul 2019
Email Print Friendly Share TULSA, July 29, 2019 (GLOBE NEWSWIRE) — Mid-Con Energy Partners, LP (NASDAQ: MCEP) (“Mid-Con Energy” or the “Partnership”) is pleased to... Read More →
NXP Semiconductors Reports Second Quarter 2019 Results
/
Date30 Jul 2019
Email Print Friendly Share EINDHOVEN, The Netherlands, July 29, 2019 (GLOBE NEWSWIRE) — NXP Semiconductors N.V. (NASDAQ: NXPI) today reported financial results for the second... Read More →
Integra LifeSciences Acquires Arkis Biosciences Inc.
/
Date30 Jul 2019
Email Print Friendly Share PLAINSBORO, N.J., July 29, 2019 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today... Read More →
Real World Evidence (RWE) Solutions Market to Reach $1.64 billion by 2024- Exclusive Report by Meticulous Research®
/
Date30 Jul 2019
Email Print Friendly Share London, July 29, 2019 (GLOBE NEWSWIRE) — According to a new market research report “Real World Evidence Solutions Market by Component (RWD,... Read More →
MediciNova Announces MN-166 (ibudilast) ALS Abstract Accepted for Presentation at the 30th International Symposium on ALS/MND in Perth, Australia
/
Date30 Jul 2019
Email Print Friendly Share LA JOLLA, Calif., July 29, 2019 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV)... Read More →
Livongo Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
/
Date30 Jul 2019
Email Print Friendly Share MOUNTAIN VIEW, Calif., July 29, 2019 (GLOBE NEWSWIRE) — Livongo Health, Inc., (Nasdaq: LVGO) today announced the closing of its initial... Read More →